Sahajanand Medical Technologies LimitedSMTCorporate

Medical Equipment & Supplies Latest results: Sep 2026 2 quarters of data

₹504.65

MCap ₹5,130 Cr

AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.

₹159 Cr

Sales · Sep 2026

₹20 Cr

Operating Profit · Sep 2026

12.9%

OPM % · Sep 2026

₹10 Cr

Net Profit · Sep 2026

₹1.00

EPS · Sep 2026

📝 Sahajanand Medical Technologies Limited — results explained

Quarter ended September 2026 (Q2 FY27)

Sahajanand Medical Technologies Limited reported revenue of ₹159 crore for the quarter ended September 2026 (Q2 FY27), and up 3.4% sequentially over the June 2026 quarter.

Net profit stood at ₹10 crore. Earnings per share (EPS) came in at ₹1.00.

Operating profit stood at ₹20 crore — an operating margin (OPM) of 12.9%.

Valuation snapshot

At the current price of ₹504.65, SMT has a market capitalisation of ₹5,130 crore.

Within the Medical Equipment & Supplies industry, it is the largest of the 14 companies we track by market value.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close

Valuation

Market Cap ?

₹5,130 Cr

Current Price ?

₹504.6

P/E ?

N/A

Industry P/E ?

27.30

P/B ?

7.35

P/S ?

N/A

P/FCF ?

N/A

Enterprise Value ?

₹5,343 Cr

EV/EBITDA ?

N/A

PEG ?

N/A

Earnings Yield ?

N/A

Dividend Yield ?

N/A

Profitability & Returns

Sales (TTM) ?

N/A

OPM ?

N/A

Profit after tax (TTM) ?

N/A

EPS (TTM) ?

N/A

ROCE ?

N/A

ROE ?

N/A

ROA ?

N/A

Growth

Sales — latest qtr ?

₹159 Cr

PAT — latest qtr ?

₹10 Cr

YoY qtr sales growth ?

N/A

YoY qtr profit growth ?

N/A

Sales growth (3y) ?

N/A

Sales growth (5y) ?

N/A

Profit growth (3y) ?

N/A

Profit growth (5y) ?

N/A

Financial Health

Debt ?

₹213 Cr

Debt to Equity ?

0.31

Interest Coverage ?

N/A

Ownership

Promoter holding ?

N/A

Change in promoter holding ?

N/A

FII holding ?

N/A

DII holding ?

N/A

Market

Return 3 months ?

33.6%

Return 6 months ?

33.6%

🗓️ Quarterly results (2 quarters · ₹ Cr)

same fiscal quarter as Sep bestweakest per row · for costs (interest, NPAs) low is best Highlight

Metric	Jun 2026	Sep 2026	YoY %	QoQ %
Sales	153	159	—	+3.4%
Operating Profit	21	20	—	-0.5%
Other Income	1	2	—	+38.8%
Interest	4	4	—	+1.8%
Depreciation	5	5	—	+6.9%
Profit Before Tax	13	13	—	+0.3%
Net Profit	9	10	—	+5.5%
EPS	0.95	1.00	—	+5.3%
OPM %	13.4%	12.9%	—	-3.7%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Annual rollup not yet available We need at least 3 quarters of a fiscal year to compute annual figures. This symbol does not yet have a complete fiscal year in our database.

🏛️ Balance Sheet (latest 1 periods)

Metric	Sep 2026	% Chg
Equity Capital	10	—
Reserves	688	—
Borrowings	213	—
Other Liabilities	140	—
Total Liabilities	1,051	—
Fixed Assets	92	—
CWIP	7	—
Investments	502	—
Other Assets	450	—
Total Assets	1,051	—

📦 Working Capital (latest 1 periods)

Metric	Sep 2026	% Chg
Inventories	141	—
Trade Receivables	125	—
Trade Payables	48	—

⚖️ Peer comparison

Industry: Medical Equipment & Supplies · 14 companies · full page →

#	Company	CMP	MCap (Cr)	P/E	Sales TTM	NP TTM	OPM%	NPM%	ROE%	ROCE%	D/E	Sales YoY%	NP YoY%	Qtr Rev Δ%	Qtr NP Δ%
1	SMT Sahajanand Medical	₹502.00	5,103	—	—	—	—	—	—	—	0.45	—	—	—	—
2	FISCHER Fischer Medical	₹33.50	2,293	85.2	367	24	12.3%	6.7%	—	—	—	178.6%	2051.4%	249.4%	-24.3%
3	TARSONS Tarsons Products	₹330.00	1,756	234.0	463	7	26.6%	1.6%	1.2%	5.0%	0.63	-66.3%	-81.4%	20.8%	-110.4%
4	DENTALKART Vasa Denticity	₹563.10	977	79.8	312	12	4.6%	3.9%	6.3%	9.0%	0.00	16.7%	-28.5%	18.3%	4.2%
5	543916 Hemant Surgical	₹193.85	544	13.9	231	18	10.4%	7.8%	—	—	—	—	—	187.9%	160.0%
6	543363 Prevest Denpro	₹616.50	456	32.8	75	23	35.7%	29.9%	—	—	—	13.6%	17.6%	23.7%	24.8%
7	QMSMEDI QMS Medical	₹185.89	359	52.7	162	7	13.1%	4.1%	12.2%	13.0%	0.65	5.1%	-47.9%	23.7%	-0.8%
8	NURECA Nureca	₹301.60	302	60.4	174	5	3.5%	2.7%	2.5%	3.0%	0.04	34.0%	146.7%	55.1%	11.6%
9	530427 Choksi Asia	₹65.64	119	7.2	47	5	14.5%	11.1%	—	—	—	61.1%	173.2%	-22.5%	-10.1%
10	527005 Shree Pacetronix	₹168.25	55	19.2	21	3	24.8%	15.3%	—	—	—	28.7%	324.3%	-8.3%	14.5%
11	544143 Royal Sense	₹139.00	44	24.7	38	3	12.8%	8.0%	—	—	—	—	—	2.5%	-5.4%
12	533212 GKB Ophthalmics	₹104.90	35	17.6	150	6	7.0%	3.7%	—	—	—	36.8%	142.7%	2.3%	388.5%
13	531380 Centenial Surgical	₹110.90	27	—	56	-1	10.7%	-2.6%	—	—	—	0.6%	-38.1%	18.6%	1937.8%
14	542765 Transpact Enterprises	₹325.00	4	140.1	0	0	63.2%	47.4%	—	—	—	—	—	12.5%	-20.0%

❓ Frequently asked questions

What was Sahajanand Medical Technologies Limited's revenue in Q2 FY27?

Sahajanand Medical Technologies Limited reported revenue of ₹159 crore for the quarter ended September 2026 (Q2 FY27), and up 3.4% sequentially over the June 2026 quarter.

What was Sahajanand Medical Technologies Limited's net profit in Q2 FY27?